Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The HLA system and Itsenko-Cushing disease].

R P Manishkina, A B Andrusenko, S I Donskov

    Terapevticheskii Arkhiv
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Hyper- and hypoaldosteronism].

    Klinicheskaia meditsina·2008
    Same author

    [Adrenal gland surgery].

    Vestnik Rossiiskoi akademii meditsinskikh nauk·2006
    Same author

    Vascular endothelium growth factor in the sera of patients with adrenal tumors.

    Bulletin of experimental biology and medicine·2005
    Same author

    [Diabetes mellitus and the heart].

    Klinicheskaia meditsina·2005
    Same author

    Serum interleukin-6 in patients with adrenal tumors.

    Bulletin of experimental biology and medicine·2004
    Same author

    [Anesthesia for the surgeries in patients with diabetes mellitus].

    Anesteziologiia i reanimatologiia·2004
    Same journal

    [History of the Moscow Scientific Society of Cardiology].

    Terapevticheskii arkhiv·2026
    Same journal

    [Antiphospholipid syndrome: ophthalmologic manifestations. A review].

    Terapevticheskii arkhiv·2026
    Same journal

    [Uric acid and mitochondrial dysfunction: a review].

    Terapevticheskii arkhiv·2026
    Same journal

    [Rheumatoid nodule in the myocardium as part of the chain in a clinical detective. Case report].

    Terapevticheskii arkhiv·2026
    Same journal

    [Immunoglobulin G4-related retroperitoneal fibrosis: clinical, laboratory, imaging, and histopathological features in a Russian single-center cohort].

    Terapevticheskii arkhiv·2026
    Same journal

    [Cutaneous manifestations of systemic lupus erythematosus and coexisting dermatologic conditions].

    Terapevticheskii arkhiv·2026
    See all related articles

    Individuals with specific Human Leukocyte Antigen (HLA) antigens, including A10, B8, and B27, show a higher risk for developing Icenko-Cushing

    Area of Science:

    • Immunogenetics
    • Endocrinology
    • Human Leukocyte Antigen (HLA) system

    Context:

    • Icenko-Cushing's disease is a complex endocrine disorder.
    • The role of genetic predisposition in Icenko-Cushing's disease is under investigation.
    • Human Leukocyte Antigen (HLA) genes are crucial for immune system regulation and have been associated with various diseases.

    Purpose:

    • To investigate the association between specific Human Leukocyte Antigen (HLA) antigens and Icenko-Cushing's disease.
    • To compare the frequency of HLA antigens in patients with Icenko-Cushing's disease and a control group.
    • To identify potential HLA markers for assessing the risk of developing Icenko-Cushing's disease.

    Summary:

    • A study of 54 Icenko-Cushing's disease patients revealed a significantly higher prevalence of HLA antigens A10 (50.7%), B8 (27.3%), and B27 (26.2%) compared to controls (17.8%, 16.3%, and 7.4%, respectively).

    Related Experiment Videos

  • Specific HLA haplotypes, such as A10-B8 and A10-B27, were also found at increased frequencies in patients, suggesting a genetic linkage.
  • These findings indicate a potential correlation between the presence of these HLA antigens and an elevated risk for Icenko-Cushing's disease.

    • Impact:

    • Identifies specific HLA antigens as potential risk factors for Icenko-Cushing's disease.
    • May facilitate the development of genetic screening tools for early risk assessment.
    • Contributes to understanding the immunogenetic basis of Icenko-Cushing's disease.